Effect of GTx-024, a selective androgen receptor modulator (SARM), on stair climb performance and quality of life (QOL) in patients with cancer cachexia.

被引：2

作者：

Steiner, M. S. ^{[1
]}

Barnette, K. G. ^{[1
]}

Hancock, M. L. ^{[1
]}

Dodson, S. T. ^{[1
]}

Rodriguez, D. ^{[1
]}

Morton, R. A. ^{[1
]}

机构：

[1] GTx Inc, Memphis, TN USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期

关键词：

D O I：

10.1200/jco.2010.28.15_suppl.9147

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

9147

引用

页数：1

共 11 条

[1] A phase II clinical trial of the combination of pembrolizumab and selective androgen receptor modulator GTx-024 in patients with advanced androgen receptor positive triple negative breast cancer
Yuan, Yuan
Frankel, Paul
Synold, Timothy
Lee, Peter
Yost, Susan
Martinez, Norma
Tang, Aileen
Mendez, Blanca
Schmolze, Daniel
Apple, Sophia
Hurria, Arti
Waisman, James
Somlo, George
Tank, Niki
Sedrak, Mina
Mortimer, Joanne
CANCER RESEARCH, 2018, 78 (04)
[2] Pharmacokinetic drug interactions of the selective androgen receptor modulator GTx-024(Enobosarm) with itraconazole, rifampin, probenecid, celecoxib and rosuvastatin
Christopher C. Coss
Amanda Jones
James T. Dalton
Investigational New Drugs, 2016, 34 : 458 - 467
[3] Pharmacokinetic drug interactions of the selective androgen receptor modulator GTx-024(Enobosarm) with itraconazole, rifampin, probenecid, celecoxib and rosuvastatin
Coss, Christopher C.
Jones, Amanda
Dalton, James T.
INVESTIGATIONAL NEW DRUGS, 2016, 34 (04) : 458 - 467
[4] A phase II clinical trial of pembrolizumab and selective androgen receptor modulator GTx-024 in patients with advanced androgen receptor-positive triple-negative breast cancer.
Lee-Bitar, Jin Sun
Frankel, Paul Henry
Yost, Susan Elaine
Synold, Timothy W.
Martinez, Norma
Tang, Aileen
Schmolze, Dan
Apple, Sophia
Hurria, Arti
Waisman, James Ross
Somlo, George
Patel, Niki Tank
Sedrak, Mina S.
Mortimer, Joanne E.
Yuan, Yuan
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[5] "KEGELS IN A BOTTLE": PRELIMINARY RESULTS OF A SELECTIVE ANDROGEN RECEPTOR MODULATOR (GTX-024) FOR THE TREATMENT OF STRESS URINARY INCONTINENCE IN POST-MENOPAUSAL WOMEN
Peters, K.
Johnston, M. A.
Small, S.
Taylor, R.
Killinger, K.
Sirls, L.
NEUROUROLOGY AND URODYNAMICS, 2017, 36 : S55 - S56
[6] EFFECT OF OSTARINE (ENOBOSARM/GTX024), A SELECTIVE ANDROGEN RECEPTOR MODULATOR, ON ADIPOCYTE METABOLISM IN WISTAR RATS
Leciejewska, N.
Pruszynska-Oszmalek, E.
Bien, J.
Nogowski, L.
Kolodziejski, P. A.
JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2019, 70 (04): : 525 - 533
[7] A SELECTIVE ANDROGEN RECEPTOR MODULATOR (SARM), IMPROVES PHYSICAL FUNCTION IN NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS WITH CANCER CACHEXIA
Dodson, Shontelle T.
Dobs, Adrian
Hancock, Michael L.
Barnette, Gary
Johnston, Mary A.
Steiner, Mitchell S.
JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S308 - S309
[8] A Randomized Placebo Controlled Trial of a Selective Androgen Receptor Modulator in patients with cancer cachexia
Morton, Ronald
Barnette, K. Gary
Hancock, Michael
Rodriguez, Domingo
Dalton, James
Steiner, Mitchell
CANCER RESEARCH, 2009, 69
[9] AN ORAL NONSTEROIDAL SELECTIVE ANDROGEN RECEPTOR MODULATOR, TEI-SARM2, PREVENTS DISUSE MUSCLE ATROPHY AND CANCER CACHEXIA
Kanou, M.
Horie, K.
Nakamura, K.
Makino, A.
Sugiyama, H.
Yamana, K.
OSTEOPOROSIS INTERNATIONAL, 2016, 27 : S186 - S186
[10] The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial
Dalton, James T.
Barnette, Kester G.
Bohl, Casey E.
Hancock, Michael L.
Rodriguez, Domingo
Dodson, Shontelle T.
Morton, Ronald A.
Steiner, Mitchell S.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2011, 2 (03) : 153 - 161

← 1 2 →